Skip to main content
NYSE:UPC

Universe Pharmaceuticals Stock Forecast, Price & News

$3.19
0.00 (0.00 %)
(As of 05/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$3.11
$3.31
50-Day Range
$3.06
$5.65
52-Week Range
$3.01
$11.99
Volume232,768 shs
Average Volume3.57 million shs
Market Capitalization$69.38 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
30 days | 90 days | 365 days | Advanced Chart
Receive UPC News and Ratings via Email

Sign-up to receive the latest news and ratings for Universe Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.


About Universe Pharmaceuticals

Universe Pharmaceuticals INC, a pharmaceutical company, engages in the manufacture, marketing, distribution, and sale of traditional Chinese medicine derivative products in China. It offers products for the treatment and relief for common chronic health conditions in the elderly for the physical wellness and longevity; and cold and flu medications. The company also distributes and sells third-party producers, including biomedical drugs, medical instruments, traditional Chinese medicine pieces products, and dietary supplements. Its customers include pharmaceutical companies, hospitals, clinics, and drugstore chains. The company was incorporated in 2019 and is based in Ji'an, China. Universe Pharmaceuticals INC operates as a subsidiary of Sununion Holding Group Limited.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorN/A
CUSIPN/A
CIKN/A
Phone86 79 6840 4999
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual SalesN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap$69.38 million
Next Earnings DateN/A
OptionableNot Optionable

MarketRank

Overall MarketRank

0.00 out of 5 stars

Biotechnology Industry

147th out of 159 stocks

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Universe Pharmaceuticals (NYSE:UPC) Frequently Asked Questions

What stocks does MarketBeat like better than Universe Pharmaceuticals?

Wall Street analysts have given Universe Pharmaceuticals a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Universe Pharmaceuticals wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Who are Universe Pharmaceuticals' key executives?

Universe Pharmaceuticals' management team includes the following people:
  • Mr. Gang Lai, CEO & Chairman (Age 53)
  • Ms. Lin Yang, CFO & Director (Age 44)

Who are some of Universe Pharmaceuticals' key competitors?

When did Universe Pharmaceuticals IPO?

(UPC) raised $30 million in an initial public offering on Tuesday, March 23rd 2021. The company issued 5,000,000 shares at a price of $5.00-$7.00 per share. Univest Securities, LLC acted as the underwriter for the IPO.

What is Universe Pharmaceuticals' stock symbol?

Universe Pharmaceuticals trades on the New York Stock Exchange (NYSE) under the ticker symbol "UPC."

When did the company's quiet period expire?

Universe Pharmaceuticals' quiet period expired on Monday, May 3rd. Universe Pharmaceuticals had issued 5,000,000 shares in its public offering on March 23rd. The total size of the offering was $25,000,000 based on an initial share price of $5.00. During the company's quiet period, insiders and any underwriters involved in the IPO were restricted from issuing any earnings forecasts or research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

Who are Universe Pharmaceuticals' major shareholders?

Universe Pharmaceuticals' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include Millennium Management LLC (0.15%) and Jane Street Group LLC (0.07%).

Which major investors are buying Universe Pharmaceuticals stock?

UPC stock was acquired by a variety of institutional investors in the last quarter, including Millennium Management LLC, and Jane Street Group LLC.

How do I buy shares of Universe Pharmaceuticals?

Shares of UPC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Universe Pharmaceuticals' stock price today?

One share of UPC stock can currently be purchased for approximately $3.19.

How much money does Universe Pharmaceuticals make?

Universe Pharmaceuticals has a market capitalization of $69.38 million.

What is Universe Pharmaceuticals' official website?

The official website for Universe Pharmaceuticals is www.dzrzy.com.

How can I contact Universe Pharmaceuticals?

The company can be reached via phone at 86 79 6840 4999.


This page was last updated on 5/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.